AerSale Corporation
NASDAQ:ASLEAirlines, Airports & Air Services
-$0.11 today
- Market cap
- $242.47M
- Beta
- 0.27
- P/E (TTM)
- 25.5
- EPS (TTM)
- $0.25
Volume 0.30M
Average 0.37M
ASLE Interest Expense
Cost of servicing the company's debt during the period.
AerSale CorporationNASDAQ: ASLE
Interest Expense · Q1 FY2026 · quarter ended Mar 2026
Interest expense turns negative
Q1 FY2026 interest expense was -$2.13M, compared with $1.18M a year earlier. Trailing-twelve-month interest expense was $5.02M.
Context
- Interest expense amounted to 2.5% of revenue in FY2025, up 0.8 pp from a year earlier.
- Interest expense increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly interest expense holds near -$2.13M or moves back toward the trailing-twelve-month quarterly average of $1.25M.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Expense history
USD · from the income statement
- Latest · FY2025
- 8.33M USD
- Year-over-year change
- +46.1%
- 4-year CAGR
- +70.7%
| Period | Period end | Interest Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.33M | +46.1% |
| FY2024 | 2024-12-31 | 5.7M | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | -100.0% |
| FY2021 | 2021-12-31 | 980K | — |
Interest Expense vs competitors
How ASLE compares with its peers on the latest reported figures
- ASLE's LTM Mar 2026 interest expense of $5.02M is the 5th highest of the 11 companies compared; the peer median is $4.49M.
- Its year-over-year change of -15.6% is the 6th highest of 9, against a peer median of -1.7%.
- Interest expense amounts to 1.5% of revenue for ASLE, versus a peer median of 1.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $50.85M | +0.6% | — | 35.4% | |
| LTM Mar 2026 | $38.7M | -0.5% | +6.1% | 1.7% | |
| LTM Mar 2026 | $21.3M | -2.8% | +37.2% | 5.5% | |
| LTM Apr 2026 | $16.77M | -38.4% | +6.8% | 4.1% | |
| LTM Mar 2026 | $5.02M | -15.6% | — | 1.5% | |
| LTM Mar 2026 | $4.99M | -45.8% | +44.6% | 0.9% | |
| LTM Mar 2026 | $3.98M | +81.7% | +59.3% | 0.9% | |
| LTM Mar 2026 | $1.69M | -92.0% | -19.0% | 2.7% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $269.18K | +754.6% | +72.2% | 0.2% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | — | |
| Peer median (excluding ASLE) | $4.49M | -1.7% | +37.2% | 1.7% | |
Competitors are the stored peer set for ASLE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 340.44M | 408.54M | 334.5M | 345.07M | 335.29M |
| Cost of Revenue | 221.05M | 257.15M | 242.08M | 241.13M | 229.51M |
| Gross Profit | 119.39M | 151.39M | 92.42M | 103.94M | 105.77M |
| Gross Margin | 35.1% | 37.1% | 27.6% | 30.1% | 31.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 77.5M | 96.35M | 103.19M | 94.19M | 89.98M |
| Operating Expenses | 62.73M | 96.35M | 103.19M | 94.19M | 89.98M |
| Depreciation & Amortization | 13M | 10.98M | 10.82M | 16.41M | 19.33M |
| EBITDA | 61.75M | 66.89M | 3.14M | 29.95M | 38.19M |
| EBITDA Margin | 18.1% | 16.4% | 0.9% | 8.7% | 11.4% |
| Operating Income | 56.66M | 55.05M | (10.77M) | 9.74M | 15.79M |
| Operating Margin | 16.6% | 13.5% | -3.2% | 2.8% | 4.7% |
| Interest Income | 0 | 0 | 155K | 0 | 0 |
| Interest Expense | 980K | 0 | 0 | 5.7M | 8.33M |
| Other Income / Expenses | (8.89M) | 2.84M | 3.09M | (1.91M) | (5.26M) |
| Income Before Tax | 47.77M | 57.88M | (7.68M) | 7.84M | 10.53M |
| Pre-Tax Margin | 14.0% | 14.2% | -2.3% | 2.3% | 3.1% |
| Income Tax Expense | 11.66M | 14.02M | (2.12M) | 1.99M | 1.95M |
| Net Income | 36.12M | 43.86M | (5.56M) | 5.85M | 8.58M |
| Net Margin | 10.6% | 10.7% | -1.7% | 1.7% | 2.6% |
| EPS (Basic) | 0.84 | 0.85 | (0.15) | 0.11 | 0.18 |
| EPS (Diluted) | 0.76 | 0.83 | (0.15) | 0.11 | 0.18 |
| Weighted Avg Shares | 43.19M | 51.57M | 51.29M | 53.11M | 47.2M |
| Weighted Avg Shares (Diluted) | 47.31M | 53.15M | 51.46M | 53.36M | 47.77M |
AerSale Corporation
NASDAQ:ASLE
Intrinsic Alpha fair value
Locked
Current Price
$5.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.